Modern medical innovation is essential to human life expectancy. A Life for the nationals of 52 countries, the long-term study showed that people in these countries between 1986-2000, the average life expectancy has increased for two years, digital thermometer 40% due to the use of innovative medicines.
Similarly, in China, along with the application of innovative drugs, clinical thermometer many of the deadly disease of the past have been overcome in recent years, Chinese urban residents of major diseases, the mortality rate has declined.
New drug application is expected to overcome the incurable disease. New drug can significantly improve the quality of life of patients. ear thermometer Data show that the use of new anti-cancer drugs, since 1975 the American Cancer 5-year survival significantly improve; Each year, digital blood pressure monitor thousands of patients with rheumatoid arthritis over the world as the rational use of drugs to avoid disability. Many Chinese also confirmed academic research of innovative medicines to improve people's quality of life plays a significant role.
However, the high cost of innovative drugs, people think that this is leading cause of the high economic burden of disease. Pharmaceutical innovation is a long process that requires high R & D expenses paid. 5000-10000 kinds of compounds, an average of only one to become new drugs, the development of a new drug takes an average of 10-15 years, 8-10 million dollars invested. Most of the multinational pharmaceutical companies have invested huge R & D every year, accounting for 16% of annual sales.
The industry said the cost of drugs only from the perspective of understanding, to control drug spending some one-sided, and difficult to optimize the medical and health expenses. Only the best treatment given to patients to prevent disease progression can we avoid paying more money and resources. New drug can effectively curb the disease increased, to avoid the high cost of treatment have disease progression, drug therapy as soon as possible to save a reasonable surgical, medical equipment, hospital fees and so on, innovative drugs can also reduce the demand for medical services and help alleviate the medical services, inadequate supply of pressure. As China's large population, a small number of current staff, if in China to promote the rational use of drug treatment ease the pressure on health care system should be explored.
Currently, less innovative drugs in China, most pharmaceutical companies are still concentrated in low value-added areas of generic drugs, according to statistics, China had said more than 900 enterprises in the production of drugs norfloxacin this simple, low-level will inevitably lead to excessive duplication and disorderly competition. Low profits, R & D costs are not high, according to statistics, the increase in generic production-oriented enterprises are only 2% of sales into research and development.
At present, the situation is improving. China's research institutes for the development of SARS vaccines, flu vaccine made a significant contribution to increasing the national investment in science and technology and policy support, local R & D outsourcing company, is also encouraging the development of modern medicine. If you want the Chinese market environment more conducive to encouraging innovation, I believe that policy certain industries, intellectual property protection, infrastructure construction, the existing pharmaceutical industry, adequate human resources and other aspects of high-quality gradually improved.
Foreign Investment Enterprises Association of Pharmaceutical Industry Research and Development Committee, said Mr. Liu Zhenxian president to improve the business environment, support and protect innovative companies, will encourage the production-oriented enterprises in industrial upgrading and innovation. Mature experience of international pharmaceutical market, the Government's incentive policies to guide the healthy development of the pharmaceutical industry is essential. The Government continued to encourage enterprises to technology and quality innovation, improve drug quality management system into the same time, the price leverage, medical insurance reimbursement and clinical use of the interface between management, establishment of incentives to promote enterprise initiatives will greatly enhance the quality of medicines positive innovation, promote the development of the industry and ultimately benefit the patient.